Effects of RNAi-mediated gene silencing of LRIG1 on proliferation and invasion of glioma cells

Abstract

The effects of RNAi-mediated gene silencing of LRlG1 on proliferation and invasion of the human glioma cell line U251-MG and the possible mechanisms were explored in this study. The plasmids pGenesil2-LRIG1-shRNA1 and pGenesil2-LRIG1-shRNA2 were transfected into U251-MG glioma cells respectively by using Lipofectamine 2000 and the transfected cells in which the LRIG1 expression was stably suppressed were selected by G418. The cells transfected with negative shRNA served as control. The expression levels of LRIG1 mRNA and protein were measured by qRT-PCR and Western blotting, respectively. The cell cycle was analyzed by flow cytometry. The results showed that LRIG1 mRNA expression was reduced by 70% and 58% and LRIG1 protein expression by 58% and 26% in U251-MG cells transfected with pGenesil2-LRIG1-shRNAl and pGenesil2-LRIG1-shRNA2 relative to the negative shRNA-transfected U251-MG cells. The proliferative capacity of the LRIG1 specific siRNA-transfected cells was stronger than that of control cells. Cell cycle analysis showed that silencing LRIG1 significantly increased the percentage of S phase cells and the proliferation index (P<0.01). Moreover, silencing LRIG1 could promote the invasion of U251-MG cells (P<0.05). These findings suggested that LRIG1-targeting siRNA can exert a dramatically inhibitory effect on RNA transcription and protein expression of LRIG1, and LRIG1 down-regulation could promote the proliferation of U251-MG cells, arrest U251-MG cells in S phase, and enhance the invasion of U251-MG cells.

Keywords

glioma / LRIG1 / cell proliferation / invasion

References

[1] FariaM.H., KhayatA.S., BurbanoR.R., et al.. c -MYC amplification and expression in astrocytic tumors. Acta Neuropathol, 2008, 116(1): 87-95

[2] ParkC.M., ParkM.J., KwakH.J., et al.. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res, 2006, 66(17): 8511-8519

[3] OwaT., YoshinoH., YoshimatsuK., et al.. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem, 2001, 8(12): 1487-1503

[4] FrederickL., WangX.Y., EleyG., et al.. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res, 2000, 60(5): 1383-1387

[5] NilssonJ., VallboC., GuoD., et al.. Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun, 2001, 284(5): 1155-1161

[6] GurG., RubinC., KatzM., et al.. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J, 2004, 23(16): 3270-3281

[7] LaederichM.B., Funes-DuranM., YenL., et al.. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J Biol Chem, 2004, 279(45): 47 050-47 056

[8] WangB., HanL., ChenR., et al.. Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol Ther, 2009, 8(11): 1018-1023

[9] CaiM., HanL., ChenR., et al.. Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell apoptosis, adhesion and invasion of glioblastoma cell (GL15). Cancer Lett, 2009, 278(1): 104-112

[10] EgebladM., WerbZ.. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2002, 2(3): 161-174

[11] VanMeterT.E., RoopraiH.K., KibbleM.M., et al.. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol, 2001, 53(2): 213-235

[12] ChattopadhyayP., BanerjeeM., SarkarC., et al.. Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells. Oncogene, 1995, 11(12): 2711-2714

[13] ParkM.J., KimM.S., ParkI.C., et al.. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res, 2002, 62(21): 6318-6322

[14] KodaliR., HajjouM., BermanA.B., et al.. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovasc Res, 2006, 69(3): 706-715

[15] AlperO., Bergmann-LeitnerE.S., BennettT.A., et al.. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J Natl Cancer Inst, 2001, 93(18): 1375-13784

[16] CoxG., JonesJ.L., O’ByrneK.J.. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res, 2000, 6(6): 2349-2355

[17] FurnariF.B., FentonT., BachooR.M., et al.. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev, 2007, 21(21): 2683-2710

[18] HuangP.H., XuA.M., WhiteF.M.. Oncogenic EGFR signaling networks in glioma. Sci Signal, 2009, 2(87): re6

[19] ZhuJ., BlenisJ., YuanJ.. Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc Natl Acad Sci USA, 2008, 105(18): 6584-6589